Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma
The complexity of the pathogenetic mechanisms of the development of chronic inflammation in asthma determines its heterogeneity and insufficient treatment effectiveness. Nuclear transcription factors, which include peroxisome proliferator-activated receptors, that is, PPARs, play an important role i...
Saved in:
| Main Authors: | Oxana Yu. Kytikova, Juliy M. Perelman, Tatyana P. Novgorodtseva, Yulia K. Denisenko, Viktor P. Kolosov, Marina V. Antonyuk, Tatyana A. Gvozdenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2020/8906968 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polyunsaturated fatty acids and lipid mediators controlling chronic inflammation in asthma
by: Oxana Yu. Kytikova, et al.
Published: (2023-06-01) -
Associations of delta fatty acid desaturase gene polymorphisms with lipid metabolism disorders
by: Oksana Yu. Kytikova, et al.
Published: (2021-12-01) -
Brain-derived neurotrophic factor and coronary artery disease
by: Oksana Yu. Kytikova, et al.
Published: (2022-06-01) -
The role of neurotrophic growth factors in the pathophysiology of bronchial asthma associated with obesity
by: O. Yu. Kytikova, et al.
Published: (2021-04-01) -
Specificities of small airways dysfunction development in patients with mild asthma
by: Elena E. Mineeva, et al.
Published: (2021-03-01)